Published March 14, 2020
| Version 3.1
Patent
Open
An Antiviral Formulation consisting of Viral DNA Gyrase & RNA Polymerase Suppressive Protopanaxatriol Analouges for the Treatment of Coronaviral Infections
Authors/Creators
Description
A Formulation with Protopanaxatriol Class Glucopyranoside Analouges that exerts Simultanoues RNA Dependent RNA Polymerase and Viral DNA Gyrase Suppressive Properties for the Treatment of Coronaviral & Adenoviral Infections
Files
2013_05054.pdf
Files
(269.8 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:c90e9f50f27cb9658f3dbea12f402725
|
130.7 kB | Preview Download |
|
md5:f35131a706d25d9792dc9e6a5d56c080
|
139.1 kB | Preview Download |